title: The effect of urocortin on ingestive behaviours and brain Fos immunoreactivity in mice.
abstract: The influence of urocortin (UCN) on ingestive behaviours and brain neural activity, as measured immunohistochemically by the presence of Fos protein, was determined in mice. Rat UCN was administered by continuous intracerebroventricular (ICV) or subcutaneous (SC) infusion. ICV infusion of UCN (100 ng/h, 14 days) transiently reduced daily food and water intakes (days 1-4) but body weight was reduced from day 2 into the post-infusion period. Sodium intake was reduced from day 3 to the end of infusion. SC infusion of UCN caused similar but smaller reductions in food and water intakes and body weight, without change in sodium intake. In separate experiments, Fos immunoreactivity was increased in several brain nuclei known to be involved in the control of body fluid and energy homeostasis, e.g. central nucleus of the amygdala, median preoptic nucleus, bed nucleus of the stria terminalis and arcuate nucleus. Increased Fos expression was similar for ICV and SC infusions when measured on days 2-3 or 6-7 of infusion. In conclusion, increases of brain activity by UCN may be associated with stimulation of adrenocorticotrophic hormone release and sympathetic nervous activity, but increases may also indicate suppression of ingestive behaviours by stimulating central inhibitory mechanisms located in areas known to control body fluid and energy homeostasis.
authors.affiliation: The Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Victoria 3010, Australia.
authors.forename: P
authors.initials: P
authors.lastname: Sinnayah
authors.forename: J R
authors.initials: JR
authors.lastname: Blair-West
authors.forename: M I
authors.initials: MI
authors.lastname: McBurnie
authors.forename: M J
authors.initials: MJ
authors.lastname: McKinley
authors.forename: B J
authors.initials: BJ
authors.lastname: Oldfield
authors.forename: J
authors.initials: J
authors.lastname: Rivier
authors.forename: W W
authors.initials: WW
authors.lastname: Vale
authors.forename: L L
authors.initials: LL
authors.lastname: Walker
authors.forename: R S
authors.initials: RS
authors.lastname: Weisinger
authors.forename: D A
authors.initials: DA
authors.lastname: Denton
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D003346:Corticotropin-Releasing Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D004326:Drinking / Q000187:drug effects; D004435:Eating / Q000187:drug effects*; D007150:Immunohistochemistry; D007276:Injections, Intraventricular; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000494:pharmacology*; D016760:Proto-Oncogene Proteins c-fos / Q000187:drug effects / Q000378:metabolism*; D012964:Sodium; D054832:Urocortins
chemical_list: D018696:Neuroprotective Agents; D016760:Proto-Oncogene Proteins c-fos; D054832:Urocortins; D003346:Corticotropin-Releasing Hormone; D012964:Sodium